NCT01503658View on ClinicalTrials.gov

Clinical Trial to Evaluate the Influence of Genotype on the Pharmacokinetics/Pharmacodynamics of Clopidogrel

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions

Influence of Genotype of Drug Metabolizing Enzyme or Transporter on the Pharmacokinetics/Pharmacodynamics of ClopidogrelInfluence of Aspirin on the Pharmacokinetics/Pharmacodynamics of Clopidogrel

Interventions

DRUG

Clopidogrel+Aspirin

Clopidogrel 75 mg, Aspirin 100 mg

Trial Locations (1)

110-744

Seoul National University Hospital Clinical Trials Center, Seoul

All Listed Sponsors

lead

Seoul National University Hospital

OTHER

NCT01503658 - Clinical Trial to Evaluate the Influence of Genotype on the Pharmacokinetics/Pharmacodynamics of Clopidogrel | Biotech Hunter | Biotech Hunter